Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles

Gynecological Endocrinology

Volumn 21, Issue 1, 2005, Pages 38-44

  Urbancsek, János ^a   Hauzman, Erik E ^a   Murber, Ákos ^a   Lagarde, Ana R ^b   Rabe, Thomas ^c   Papp, Zoltán ^a   Strowitzki, Thomas ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CA 125; In vitro fertilization; Inhibin B; Poor responders; Treatment outcome

Indexed keywords

CA 125 ANTIGEN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; INHIBIN B;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; OVARY FUNCTION; OVULATION INDUCTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANIMALS; CA-125 ANTIGEN; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; INHIBINS; OVARY; OVULATION INDUCTION; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 23244458444     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590500099438     Document Type: Article

References (69)

1. Keay SD, Uversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-7.
2. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76.
3. García JE, Jones GS, Acosta AA, Wright G Jr. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril 1983;39:174-9.
4. Seifer DB, Gardiner AC, Lambert-Messerlian G, Schneyer AL. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab 1996;81:736-9.
5. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 1996;81:1038-45.
6. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307.
7. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295-301.
8. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-91.
9. Tanbo T, Dale PO, Lunde O, Norman N, Åbyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 1992;57: 819-24.
10. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;67:110-14.
11. Farhi J, Homburg R, Ferber A, Orvieto R, Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997;12:241-3.
12. McLachlan RI, Robertson DM, Healy DL, de Kretser DM, Burger HG. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet 1986;1:1233-4.
13. Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 1996;175: 1226-30.
14. Lockwood GM, Muttukrishna S, Groome NP, Knight PG, Ledger WL. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endocrinol (Oxf) 1996;45:741-8.
15. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409-15.
16. Creus M, Peñarrubia J, Fábregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA, Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15:2341-6.
17. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-36.
18. Seifer DB, Scott RT Jr, Bergh PA, Abrogast LK, Friedman CI, Mack CK, Danforth DR. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72:63-5.
19. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-5.
20. Hughes EG, Robertson DM, Handelsman DJ, Hayward S, Healy DL, de Kretser DM. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 1990;70:358-64.
21. Pellicer A, Mari M, de los Santos MJ, Simon C, Remohi J, Tarin JJ. Effects of aging on the human ovary: the secretion of immunoreactive alpha-inhibin and progesterone. Fertil Steril 1994;61:663-8.
22. Peñarrubia J, Balasch J, Fábregues F, Carmona F, Casamitjana R, Moreno V, Calafell JM, Vanrell JA. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod 2000;15:1499-504.
23. Kenemans P, Yedema CA, Hilgers JH, Massuger LF, Verheijen RH, Thomas CM, Poels LG. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens. Eur J Obstet Gynecol Reprod Biol 1988;29:207-18.
24. Quirk JG Jr, Brunson GL, Long CA, Bannon GA, Sanders MM, O'Brien TJ. CA 125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol 1988;159:644-9.
25. Zeimet AG, Müller-Holzner E, Marth C, Daxenbichler G, Dapunt O. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril 1993;59:1028-35.
26. Ng EH, Laird SM, Li TC, Yeung WS, Ho PC. Concentrations of endometrial protein PP 14 and CA-125 in uterine flushings performed in natural and stimulated cycles. Hum Reprod 2004;19:905-10.
27. Mordel N, Anteby SO, Zajicek G, Roisman I, Treves A, Barak V. CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients. Fertil Steril 1992;57:377-80.
28. Jimena P, Castilla JA, Ramirez JP, Gil T, Acebal M, Molina R, Herruzo AJ. Follicular fluid α-fetoprotein, carcinoembryonic antigen, and CA-125 levels in relation to in vitro fertilization and gonadotropin and steroid hormone concentrations. Fertil Steril 1993;59:1257-60.
29. Chryssikopoulos A, Mantzavinos T, Kanakas N, Karagouni E, Dotsika E, Zourlas PA. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients. Fertil Steril 1996;66:599-603.
30. Miller KA, Deaton JL, Pittaway DE. Evaluation of serum CA 125 concentrations as predictors of pregnancy with human in vitro fertilization. Fertil Steril 1996;65:1184-9.
31. Vujisić S, Kupešić S, Mihaljević D, Akšamija A, Kurjak A. Evaluation of serum CA 125 concentration before and during hormonal induced cycles as predictor of IVF/ET outcome. Am J Reprod Immunol 2002;48:355-60.
32. Noci I, Maggi M, Biagiotti R, D'Agata A, Criscuoli L, Marchionni M. Serum CA-125 values on the day of oocyte retrieval are not predictive of subsequent pregnancy with in-vitro fertilization. Hum Reprod 1999;14:1773-6.
33. Barbieri RL, Niloff JM, Bast RC Jr, Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986;45:630-4.
34. Pittaway DE, Fayez JA. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 1986;46:790-5.
35. Dokras A, Habana A, Giraldo J, Jones E. Secretion of inhibin B during ovarian stimulation is decreased in infertile women with endometriosis. Fertil Steril 2000;74:35-40.
36. Hauzman E, Fedorcsák P, Klinga K, Papp Z, Rabe T, Strowitzki T, Urbancsek J. Use of serum inhibin A and human chorionic gonadotropin measurements to predict the outcome of in vitro fertilization pregnancies. Fertil Steril 2004;81:66-72.
37. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-5.
38. Fridström M, Akerlof E, Sjöblom P, Hillensjö T. Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation. Gynecol Endocrinol 1997;11:25-8.
39. Raga F, Bonilla-Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 1999;14:1431-4.
40. Chong AP, Rafael RW, Forte CC. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 1986;46: 599-603.
41. Rombauts L, Suikkari AM, MacLachlan V, Trounson AO, Healy DL. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril 1998;69:665-9.
42. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-24.
43. Brzyski RG, Muasher SJ, Droesch K, Simonetti S, Jones GS, Rosenwaks Z. Follicular atresia associated with concurrent initiation of gonadotropin- releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 1988;50:917-21.
44. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292-7.
45. Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N. Limited success using the 'flare' protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 1997;67:900-3.
46. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1987;2:645-7.
47. Schachter M, Friedler S, Raziel A, Strassburger D, Bern O, Ron-el R. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase - a function of improved embryo quality. J Assist Reprod Genet 2001;18:197-204.
48. Shaker AG, Fleming R, Jamieson ME, Yates RW, Coutts JR. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders. Fertil Steril 1992;58:919-23.
49. Toth TL, Awwad JT, Veeck LL, Jones HW Jr, Muasher SJ. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996;41:321-6.
50. Magarelli PC, Pearlstone AC, Buyalos RP. Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intra-uterine insemination cycles. Hum Reprod 1996;11:1214-19.
51. Brown JR, Liu HC, Sewitch KF, Rosenwaks Z, Berkeley AS. Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women. J Reprod Med 1995;40:620-4.
52. Noci I, Biagiotti R, Maggi M, Cinotti A, Scarselli G. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod 1998;13:531-4.
53. Noci I, Maggi M, Fuzzi B, Biagiotti R, Ricci F, Marchionni M. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome. Gynecol Endocrinol 2000;14:321-6.
54. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-40.
55. Tomás C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997;12:220-3.
56. Lass A, Skull J, McVeigh E, Margara R, Winston RM. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 1997;12:294-7.
57. Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302-5.
58. Ranieri DM, Quinn F, Makhlouf A, Khadum I, Ghutmi W, McGarrigle H, Davies M, Serhal P. Simultaneous evaluation of basal follicle-stimulating hormone and 17β-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 1998;70:227-33.
59. Fanchin R, de Ziegler D, Olivennes F, Taïeb J, Dzik A, Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod 1994;9:1607-11.
60. Dzik A, Lambert-Messerlian G, Izzo VM, Soares JB, Pinotti JA, Seifer DB. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 2000;74:1114-17.
61. Hannoun A, Abu Musa A, Awwad J, Kaspar H, Khalil A. Clomiphene citrate challenge test: cycle to cycle variability of cycle day 10 follicle stimulating hormone level. Clin Exp Obstet Gynecol 1998;25:155-6.
62. Eldar-Geva T, Robertson DM, Cahir N, Groome N, Gabbe MP, MacLachlan V, Healy DL. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Clin Endocrinol Metab 2000;85:607-13.
63. Eldar-Geva T, Margalioth EJ, Ben Chetrit A, Gal M, Robertson DM, Healy DL, Diamant YZ, Spitz IM. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 2002;17:2331-7.
64. Fawzy M, Lambert A, Harrison RF, Knight PG, Groome N, Hennelly B, Robertson WR. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod 2002;17:1535-43.
65. Lanzone A, Fulghesu AM, Guida C, Muscatello R, Caruso A, Mancuso S. Serum CA-125 levels do not depend on ovarian steroidogenesis. Fertil Steril 1990;54:415-18.
66. Tavmergen E, Sendag F, Goker EN, Levi R. Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles. Hum Reprod 2001;16:1129-34.
67. Brandenberger AW, Bersinger NA, Huber PR, Berger E, Glanzmann P, Birkhaeuser MH. CA-125 concentrations in the serum and pregnancy outcome in IVF cycles. J Assist Reprod Genet 1998;15:390-4.
68. Unkila-Kallio L, Tiitinen A, Alfthan H, Vuorela P, Stenman U, Ylikorkala O. Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free β-subunit of human chorionic gonadotropin, and common α-subunit of glycoprotein hormones. Fertil Steril 2000;74:1125-32.
69. Baalbergen A, Janssen JW, van der Weiden RM. CA-125 levels are related to the likelihood of pregnancy after in vitro fertilization and embryo transfer. Am J Reprod Immunol 2000;43:21-4.